Main Management ETF Advisors, LLC
- SEC CIK
- 0001698607
- Latest filing
- Aug 14, 2026
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by Main Management ETF Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −18,009−100.0% | Sold out | Holders |
| Q4 2025 | 18,009 | $944.0K | <0.1% | +184+1.0% | Added | Holders |
| Q3 2025 | 17,825 | $1.16M | <0.1% | −1,966−9.9% | Reduced | Holders |
| Q2 2025 | 19,791 | $963.0K | <0.1% | +324+1.7% | Added | Holders |
| Q1 2025 | 19,467 | $662.0K | <0.1% | +5,939+43.9% | Added | Holders |
| Q4 2024 | 13,528 | $532.0K | <0.1% | −1,216−8.2% | Reduced | Holders |
| Q3 2024 | 14,744 | $693.0K | <0.1% | +14,744 | New | Holders |